LONE TREE, Colo., Oct. 12, 2021 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) approval and clearance ...

Cochlear Limited announced yesterday the U.S. Food and Drug Administration clearance of three new products to be added to the company’s suite of hearing technology devices, all of which can connect to ...

Hear ye, hear ye: Patients using Cochlear’s hearing implants can now undergo routine adjustments and receive virtual counseling from their hearing health providers completely virtually via Cochlear’s ...

The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology Experience the full interactive ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...

Cochlear Limited, the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration (FDA) approval of three new products to its suite of hearing technology ...

Xinyu Li, General Manager, Greater China, Cochlear, explains the next generation technology has completely reimagined the internal components of the hearing device: "There are more than 10 years of ...